- ►sovegastro.com [PDF] DA Lieberman - Clinical Cornerstone, 2002 - Elsevier Colorectal cancer screening can prevent the development of colorectal cance
death. Screening recommendations include fecal occult blood testing,
sigmoidoscopy, radiographic imaging of the colon, and colonoscopy. This ... Cited by 17 - Related articles - BL Direct - All 7 versions
H Zou, WR Taylor, JJ Harrington, FTN Hussain … - Gastroenterology, 2009 - Elsevier We combined a melt curve assay with digital polymerase chain reaction and
validated the quantitative range. We then evaluated its ability to detect
neoplasms in 2 clinical studies. In study I, stool samples from patients ... Cited by 9 - Related articles - All 3 versions
SC Glockner, M Dhir, JM Yi, KE McGarvey, L … - Cancer Research, 2009 - AACR CRCs, although amenable to screening and early detection, still remains the
second leading cause of cancer-related mortality in the United States (5).
Current screening modalities have resulted in only a modest decrease in ... Cited by 6 - Related articles - All 2 versions
T deVos, R Tetzner, F Model, G Weiss, M … - Clinical Chemistry, 2009 - Am Assoc Clin Chem Methods: A new SEPT9 DNA methylation assay was developed for plasma. The assay
comprised plasma DNA extraction, bisulfite conversion of DNA, purification of
bisulfite-converted DNA, quantification of converted DNA by real-time PCR, ... Cited by 5 - Related articles - All 3 versions
- ►oxfordjournals.org V Melotte, MHFM Lentjes, SM van den Bosch, … - JNCI Journal of the National Cancer Institute, 2009 - jnci.oxfordjournals.org Methods: NDRG4 promoter methylation was analyzed in human colorectal cancer cell
lines, colorectal tissue, and noncancerous colon mucosa by using
methylation-specific polymerase chain reaction (PCR) and bisulfite ... Cited by 3 - Related articles - All 4 versions
P Lance - Cancer Epidemiology Biomarkers & Prevention, 2008 - AACR The population is divided into people at average (∼75%) and increased (∼25%)
risk for CRC. People at average risk for CRC are the topic of the current
discussion. The lengthening list of screening test options for average-risk ... Cited by 2 - Related articles - All 4 versions
DC Chung - Annals of Internal Medicine, 2008 - Am Coll Physicians D espite the recognition that colon cancer is largely pre- ventable, it remains
the second leading cause of cancer- related deaths in the United States.
Historically, screening approaches have sought to detect established ... Cited by 2 - Related articles - All 2 versions
- ►oxfordjournals.org T Nagasaka, N Tanaka, HM Cullings, DS Sun, … - JNCI Journal of the National Cancer Institute, 2009 - jnci.oxfordjournals.org Methods: We first analyzed methylation of the RASSF2 and SFRP2 gene promoters
from 788 primary gastric and colorectal tissue specimens to determine whether
methylation patterns could act as stage-dependent biomarkers of ... Cited by 2 - Related articles - All 3 versions
DA Ahlquist - Gastroenterology, 2009 - Elsevier Stool DNA testing has emerged as a noninvasive approach to colorectal cancer
screening. As with fecal occult blood testing, stool DNA testing offers
user-friendly features of noninvasiveness, avoidance of unpleasant ... Cited by 1 - Related articles - All 38 versions
JE Allison, MB Potter - Primary Care: Clinics in Office Practice, 2009 - Elsevier Until recently, most clinical guidelines in the United States were in general
agreement about the tests available for colorectal cancer screening,
recommending fecal occult blood tests every year, flexible sigmoidoscopy ... Related articles - All 2 versions
